GP
BIIB icon

Girard Partners’s Biogen BIIB Stock Holding History

Girard Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-532
Closed -$187K – 302
2018
Q3 		$187K Buy
+532
New +$183K 0.03% 250
2018
Q1 		– Sell
-821
Closed -$262K – 262
2017
Q4 		$262K Sell
821
-304
-27% -$97.5K 0.05% 230
2017
Q3 		$352K Buy
1,125
+160
+17% +$47.4K 0.07% 189
2017
Q2 		$262K Sell
965
-98
-9% -$25.9K 0.06% 218
2017
Q1 		$291K Buy
1,063
+176
+20% +$49.8K 0.07% 189
2016
Q4 		$252K Sell
887
-37
-4% -$11K 0.07% 188
2016
Q3 		$289K Buy
+924
New +$274K 0.1% 166

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Girard Partners's BIIB Position: Q4 2018 in Review

Girard Partners sold out of Biogen (BIIB) in Q4 2018, closing a stake of 532 shares — an estimated $187K sold.

Girard Partners first reported a position in BIIB in Q3 2016 and held it in 7 quarters. The position peaked at $352K in Q3 2017. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • Girard Partners reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • Girard Partners sold 532 Biogen shares in Q4 2018, an estimated $187K.
  • Girard Partners first reported a position in Biogen in Q3 2016 and held it in 7 quarters.
  • Girard Partners's Biogen position peaked at $352K in Q3 2017.
  • 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.